Logo image of BC8.DE

BECHTLE AG (BC8.DE) Stock Fundamental Analysis

FRA:BC8 - Deutsche Boerse Ag - DE0005158703 - Common Stock - Currency: EUR

38.23  -0.31 (-0.8%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to BC8. BC8 was compared to 71 industry peers in the IT Services industry. BC8 is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BC8 has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BC8 was profitable.
BC8 had a positive operating cash flow in the past year.
Each year in the past 5 years BC8 has been profitable.
BC8 had a positive operating cash flow in each of the past 5 years.
BC8.DE Yearly Net Income VS EBIT VS OCF VS FCFBC8.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

1.2 Ratios

BC8's Return On Assets of 5.49% is fine compared to the rest of the industry. BC8 outperforms 66.20% of its industry peers.
BC8 has a Return On Equity (11.59%) which is comparable to the rest of the industry.
BC8's Return On Invested Capital of 8.69% is in line compared to the rest of the industry. BC8 outperforms 56.34% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BC8 is in line with the industry average of 10.64%.
Industry RankSector Rank
ROA 5.49%
ROE 11.59%
ROIC 8.69%
ROA(3y)6.7%
ROA(5y)6.98%
ROE(3y)14.8%
ROE(5y)15.62%
ROIC(3y)12.02%
ROIC(5y)11.98%
BC8.DE Yearly ROA, ROE, ROICBC8.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of BC8 (3.61%) is comparable to the rest of the industry.
BC8's Profit Margin has improved in the last couple of years.
BC8 has a Operating Margin (5.18%) which is comparable to the rest of the industry.
BC8's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 18.04%, BC8 is not doing good in the industry: 80.28% of the companies in the same industry are doing better.
BC8's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.18%
PM (TTM) 3.61%
GM 18.04%
OM growth 3Y0.2%
OM growth 5Y6.64%
PM growth 3Y-3.72%
PM growth 5Y4.18%
GM growth 3Y1.35%
GM growth 5Y4.79%
BC8.DE Yearly Profit, Operating, Gross MarginsBC8.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BC8 is destroying value.
Compared to 1 year ago, BC8 has about the same amount of shares outstanding.
The number of shares outstanding for BC8 remains at a similar level compared to 5 years ago.
The debt/assets ratio for BC8 has been reduced compared to a year ago.
BC8.DE Yearly Shares OutstandingBC8.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BC8.DE Yearly Total Debt VS Total AssetsBC8.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 4.03 indicates that BC8 is not in any danger for bankruptcy at the moment.
BC8 has a better Altman-Z score (4.03) than 85.92% of its industry peers.
The Debt to FCF ratio of BC8 is 1.40, which is an excellent value as it means it would take BC8, only 1.40 years of fcf income to pay off all of its debts.
BC8 has a better Debt to FCF ratio (1.40) than 71.83% of its industry peers.
BC8 has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of BC8 (0.21) is better than 66.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.4
Altman-Z 4.03
ROIC/WACC0.7
WACC12.5%
BC8.DE Yearly LT Debt VS Equity VS FCFBC8.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.72 indicates that BC8 should not have too much problems paying its short term obligations.
BC8's Current ratio of 1.72 is fine compared to the rest of the industry. BC8 outperforms 78.87% of its industry peers.
BC8 has a Quick Ratio of 1.44. This is a normal value and indicates that BC8 is financially healthy and should not expect problems in meeting its short term obligations.
BC8 has a Quick ratio of 1.44. This is in the better half of the industry: BC8 outperforms 67.61% of its industry peers.
Industry RankSector Rank
Current Ratio 1.72
Quick Ratio 1.44
BC8.DE Yearly Current Assets VS Current LiabilitesBC8.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

3

3. Growth

3.1 Past

The earnings per share for BC8 have decreased strongly by -15.49% in the last year.
Measured over the past 5 years, BC8 shows a small growth in Earnings Per Share. The EPS has been growing by 7.58% on average per year.
The Revenue has decreased by -1.95% in the past year.
BC8 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.25% yearly.
EPS 1Y (TTM)-15.49%
EPS 3Y1.89%
EPS 5Y7.58%
EPS Q2Q%-32.61%
Revenue 1Y (TTM)-1.95%
Revenue growth 3Y5.93%
Revenue growth 5Y3.25%
Sales Q2Q%-2.82%

3.2 Future

Based on estimates for the next years, BC8 will show a small growth in Earnings Per Share. The EPS will grow by 6.76% on average per year.
The Revenue is expected to grow by 4.31% on average over the next years.
EPS Next Y2.65%
EPS Next 2Y5.99%
EPS Next 3Y6.76%
EPS Next 5YN/A
Revenue Next Year1.94%
Revenue Next 2Y3.83%
Revenue Next 3Y4.55%
Revenue Next 5Y4.31%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BC8.DE Yearly Revenue VS EstimatesBC8.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
BC8.DE Yearly EPS VS EstimatesBC8.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 21.24, which indicates a rather expensive current valuation of BC8.
Compared to the rest of the industry, the Price/Earnings ratio of BC8 is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.28, BC8 is valued a bit cheaper.
BC8 is valuated rather expensively with a Price/Forward Earnings ratio of 17.45.
The rest of the industry has a similar Price/Forward Earnings ratio as BC8.
BC8 is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.24
Fwd PE 17.45
BC8.DE Price Earnings VS Forward Price EarningsBC8.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BC8 is valued a bit more expensive than the industry average as 63.38% of the companies are valued more cheaply.
BC8's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 12.27
EV/EBITDA 10.05
BC8.DE Per share dataBC8.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BC8 does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of BC8 may justify a higher PE ratio.
PEG (NY)8.01
PEG (5Y)2.8
EPS Next 2Y5.99%
EPS Next 3Y6.76%

4

5. Dividend

5.1 Amount

BC8 has a Yearly Dividend Yield of 1.81%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 6.93, BC8 has a dividend in line with its industry peers.
Compared to the average S&P500 Dividend Yield of 2.42, BC8 is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.81%

5.2 History

On average, the dividend of BC8 grows each year by 16.00%, which is quite nice.
Dividend Growth(5Y)16%
Div Incr Years1
Div Non Decr Years6
BC8.DE Yearly Dividends per shareBC8.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

BC8 pays out 39.05% of its income as dividend. This is a sustainable payout ratio.
The dividend of BC8 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP39.05%
EPS Next 2Y5.99%
EPS Next 3Y6.76%
BC8.DE Yearly Income VS Free CF VS DividendBC8.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M
BC8.DE Dividend Payout.BC8.DE Dividend Payout, showing the Payout Ratio.BC8.DE Dividend Payout.PayoutRetained Earnings

BECHTLE AG

FRA:BC8 (7/3/2025, 12:40:56 PM)

38.23

-0.31 (-0.8%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-08 2025-08-08
Inst Owners37.72%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap4.82B
Analysts80
Price Target44.24 (15.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.81%
Yearly Dividend0.7
Dividend Growth(5Y)16%
DP39.05%
Div Incr Years1
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-5.82%
Min EPS beat(2)-9.37%
Max EPS beat(2)-2.28%
EPS beat(4)0
Avg EPS beat(4)-6.32%
Min EPS beat(4)-9.76%
Max EPS beat(4)-2.28%
EPS beat(8)2
Avg EPS beat(8)-3.15%
EPS beat(12)4
Avg EPS beat(12)-1.1%
EPS beat(16)7
Avg EPS beat(16)1.12%
Revenue beat(2)0
Avg Revenue beat(2)-0.9%
Min Revenue beat(2)-0.95%
Max Revenue beat(2)-0.86%
Revenue beat(4)1
Avg Revenue beat(4)-4.36%
Min Revenue beat(4)-16.2%
Max Revenue beat(4)0.55%
Revenue beat(8)2
Avg Revenue beat(8)-3.51%
Revenue beat(12)6
Avg Revenue beat(12)0.26%
Revenue beat(16)6
Avg Revenue beat(16)-5.63%
PT rev (1m)3.17%
PT rev (3m)2.3%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-24.13%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.59%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.6%
Valuation
Industry RankSector Rank
PE 21.24
Fwd PE 17.45
P/S 0.77
P/FCF 12.27
P/OCF 9.8
P/B 2.47
P/tB 5.09
EV/EBITDA 10.05
EPS(TTM)1.8
EY4.71%
EPS(NY)2.19
Fwd EY5.73%
FCF(TTM)3.12
FCFY8.15%
OCF(TTM)3.9
OCFY10.2%
SpS49.71
BVpS15.47
TBVpS7.52
PEG (NY)8.01
PEG (5Y)2.8
Profitability
Industry RankSector Rank
ROA 5.49%
ROE 11.59%
ROCE 12.26%
ROIC 8.69%
ROICexc 11.33%
ROICexgc 22.38%
OM 5.18%
PM (TTM) 3.61%
GM 18.04%
FCFM 6.27%
ROA(3y)6.7%
ROA(5y)6.98%
ROE(3y)14.8%
ROE(5y)15.62%
ROIC(3y)12.02%
ROIC(5y)11.98%
ROICexc(3y)15.84%
ROICexc(5y)15.71%
ROICexgc(3y)29.63%
ROICexgc(5y)28.23%
ROCE(3y)16.94%
ROCE(5y)16.89%
ROICexcg growth 3Y4.87%
ROICexcg growth 5Y7.72%
ROICexc growth 3Y-3.54%
ROICexc growth 5Y2.28%
OM growth 3Y0.2%
OM growth 5Y6.64%
PM growth 3Y-3.72%
PM growth 5Y4.18%
GM growth 3Y1.35%
GM growth 5Y4.79%
F-Score5
Asset Turnover1.52
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.4
Debt/EBITDA 0.87
Cap/Depr 67.43%
Cap/Sales 1.58%
Interest Coverage 14.61
Cash Conversion 104.38%
Profit Quality 173.83%
Current Ratio 1.72
Quick Ratio 1.44
Altman-Z 4.03
F-Score5
WACC12.5%
ROIC/WACC0.7
Cap/Depr(3y)72%
Cap/Depr(5y)67.96%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.35%
Profit Quality(3y)113.31%
Profit Quality(5y)113.66%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.49%
EPS 3Y1.89%
EPS 5Y7.58%
EPS Q2Q%-32.61%
EPS Next Y2.65%
EPS Next 2Y5.99%
EPS Next 3Y6.76%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.95%
Revenue growth 3Y5.93%
Revenue growth 5Y3.25%
Sales Q2Q%-2.82%
Revenue Next Year1.94%
Revenue Next 2Y3.83%
Revenue Next 3Y4.55%
Revenue Next 5Y4.31%
EBIT growth 1Y-15.86%
EBIT growth 3Y6.14%
EBIT growth 5Y10.1%
EBIT Next Year37.94%
EBIT Next 3Y17.48%
EBIT Next 5Y10.34%
FCF growth 1Y172.5%
FCF growth 3Y27.55%
FCF growth 5Y27.87%
OCF growth 1Y119.83%
OCF growth 3Y25.19%
OCF growth 5Y24.58%